Mahindra and Mahindra Shares: A Long-Term Bet on Diversified Growth
Mahindra and Mahindra Ltd. has outlined its long-term growth strategy, highlighting potential in each business segment. We analyze the company’s prospects and growth drivers.
Mahindra and Mahindra Ltd. has outlined its long-term growth strategy, highlighting potential in each business segment. We analyze the company’s prospects and growth drivers.
Groww’s parent company Billionbrains Garage Ventures Ltd. shares rebounded ahead of Q2 results, but what does this mean for Indian investors and the company’s future prospects?
Capillary Technologies India Ltd. debuted on the National Stock Exchange at a discount, here’s what Indian investors need to know about the listing and the company’s future plans.
Discover why Five-Star Business Finance, Sunteck Realty, and Teamlease Services have 100% buy ratings despite being in the red, and what the future holds for these stocks.
Poonawalla Fincorp Ltd. is transforming into a robust, digitally advanced, and diversified retail NBFC, with a clear path to consistent profitability. Get the latest updates and analysis on the company’s growth prospects.
Groww’s parent company Billionbrains Garage Ltd.’s profit rises 24.6% to Rs 471 crore in the second quarter of this financial year. Get the latest updates on Groww’s Q2 results and its impact on the Indian stock market.
SEBI Chairman Tuhin Kanta Pandey highlights the importance of REITs and InvITs in driving India’s next infrastructure cycle, with a focus on increasing retail participation and improving ease of doing business.
Adani Enterprises Ltd. has offloaded its remaining 7% stake in AWL Agri Business Ltd. through multiple block deals, with strong demand from investors including The Vanguard Group and ICICI Prudential Mutual Fund.
Tilaknagar Industries share price declined after the company allotted nearly 34 lakh shares to Madhusudan Kela-backed Singularity Equity Fund. Get the latest updates on the Indian stock market and stay ahead with our expert analysis.
Nirmal Bang maintains a ‘buy’ call on Sun Pharmaceutical Industries Ltd. despite minor EPS cuts due to near-term headwinds, citing strong growth in India and a robust specialty pipeline.